---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-095909"
form_type: "8-K"
ticker: "CRMD"
cik: "0001410098"
company_name: "CorMedix Inc."
filed_at: "2023-12-15T23:59:59+00:00"
generated_at: "2026-06-07T11:48:38.855410+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CorMedix EVP, General Counsel and Corporate Secretary Phoebe Mounts to depart Dec 31, 2023

## Summary
- Mutual separation approved Dec 12, 2023; Mounts ceases as General Counsel and Corporate Secretary immediately, remains EVP through Dec 31.
- Termination classified as without cause under Employment Agreement; severance contingent on signing release, cooperation, return of property, and compliance with covenants.
- No replacement named; Mounts will assist with transition until Termination Date.

## SEC filing metadata
- accession: 0001213900-23-095909
- form_type: 8-K
- ticker: CRMD
- cik: 0001410098
- company_name: CorMedix Inc.
- filed_at: 2023-12-15T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1410098/000121390023095909/0001213900-23-095909-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1410098/000121390023095909/ea190103-8k_cormedix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-095909
- JSON: https://secwatch.observer/filing/0001213900-23-095909.json
- Plain text: https://secwatch.observer/filing/0001213900-23-095909.txt

## Key facts
- Executive change
  Phoebe Mounts departed as Executive Vice President, General Counsel and Corporate Secretary at CorMedix Inc..
  - Action: separated
  - Role: Executive Vice President, General Counsel and Corporate Secretary
  source text: On December 12, 2023, upon mutual agreement between CorMedix Inc. (the “Company”) and Phoebe Mounts, Ph.D., Esq., the Company’s Executive Vice President, General Counsel and Corporate Secretary, the Board of Directors of the Company (the “Board”) approved the separation of employment of Dr. Mounts, effective December 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1410098/000121390023095909/0001213900-23-095909-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.